ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.056 GBX | +0.12% |
|
+4.51% | +1.10% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 423.8 USD | +3.31% | +5.15% | +3.92% | 8.46% | ||
| 954.8 USD | -1.56% | +5.72% | +8.75% | 7.85% | ||
| 304.6 USD | +1.43% | +9.60% | +5.55% | 7.84% | ||
| 65.02 USD | -0.67% | -0.85% | -19.82% | 7.77% | ||
| 220.7 USD | +0.83% | +2.10% | -14.73% | 3.86% | ||
| 121.9 USD | +0.66% | +9.36% | +22.56% | 3.85% | ||
| 155.2 USD | +0.58% | +3.17% | -19.17% | 2.51% | ||
| 110.8 USD | -1.83% | -11.06% | -20.36% | 2.31% | ||
| 82.46 USD | -0.14% | -1.18% | -14.59% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 5.056 | +0.12% | 9 876 |
| 24-05-07 | 5.05 | +0.35% | 17,473 |
| 24-05-03 | 5.032 | +1.49% | 19,736 |
| 24-05-02 | 4.958 | +2.00% | 2,908 |
| 24-05-01 | 4.862 | +0.49% | 23,723 |
Other stock markets
Delayed Quote London S.E.
Last update May 08, 2024 at 11:35 am
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2017-10-18
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 0 M€ |
|---|---|
| AuM 1M | 0 M€ |
| AuM 3 months | 0 M€ |
| AuM 6 months | 0 M€ |
| AuM 12 months | 0 M€ |
- Stock Market
- ETF
- BTEK ETF